Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02906787 · ClinicalTrials.gov registry record · NA
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
A NA study of Smoking Cessation and Weight Loss, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 1
- Study location
NCT02906787 is a NA study of Smoking Cessation and Weight Loss that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 288 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02906787, a NA study of Smoking Cessation and Weight Loss, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to better understand (1) why people gain weight when they quit smoking and (2) whether certain types of smoking cessation (i.e. quit smoking) counseling combined with the nicotine patch help people quit smoking and gain less weight.
Conditions Studied
Interventions
- BEHAVIORAL BAS+
- BEHAVIORAL SC
Study Locations (1)
Pennsylvania
- Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2016-09-13 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02906787
The ClinicalTrials.gov registry entry for NCT02906787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (39% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which BAS+ is the first listed.
NCT02906787 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02906787 about?
NCT02906787 is a clinical study titled "Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain". The purpose of this research study is to better understand (1) why people gain weight when they quit smoking and (2) whether certain types of smoking cessation (i.e. quit smoking) counseling combined with the nicotine patch help people quit smoking and gain less weight.
What is the current status of trial NCT02906787?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2016-09-13. Estimated completion is 2021-02-28.
What conditions does trial NCT02906787 study?
This clinical trial studies the following conditions: Smoking Cessation, Weight Loss.
What interventions are being tested in trial NCT02906787?
The interventions under investigation include: BAS+ (BEHAVIORAL), SC (BEHAVIORAL).
Who is sponsoring clinical trial NCT02906787?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02906787 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.